Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nervous system disorders
ADR ID BADD_A03031
ADR Hierarchy
17      Nervous system disorders
Description Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. [MeSH]
MedDRA Code 10029205
MeSH ID D009422
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Nervous System Diseases | Disease, Nervous System | Diseases, Nervous System | Nervous System Disease | Neurologic Disorders | Disorder, Neurologic | Disorders, Neurologic | Neurologic Disorder | Neurological Disorders | Disorder, Neurological | Disorders, Neurological | Neurological Disorder | Nervous System Disorders | Disorder, Nervous System | Disorders, Nervous System | Nervous System Disorder
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01657Paliperidone palmitate--
BADD_D01659Palonosetron--
BADD_D01660Palonosetron hydrochloride--
BADD_D01661Pamidronate disodium--
BADD_D01662Pamidronic acid0.000315%
BADD_D01663Pamine--
BADD_D01664Pancrelipase--
BADD_D01665Pancuronium bromide--
BADD_D01667Panobinostat lactate--
BADD_D01668Pantoprazole0.002977%
BADD_D01669Pantoprazole sodium--
BADD_D01670Papaverine--
BADD_D01671Papaverine hydrochloride--
BADD_D01672Paraldehyde--
BADD_D01673Parathyroid hormone--
BADD_D01674Parecoxib--
BADD_D01675Paregoric--
BADD_D01676Paricalcitol0.211905%
BADD_D01679Paroxetine0.003811%
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01684Pasireotide0.003726%
BADD_D01685Pasireotide diaspartate--
BADD_D01687Pazopanib0.054957%
BADD_D01688Pazopanib hydrochloride--
BADD_D01689Pegademase (bovine)--
BADD_D01690Pegaptanib--
BADD_D01691Pegaptanib sodium--
The 52th Page    First    Pre   52 53 54 55 56    Next   Last    Total 80 Pages
ADReCS-Target
ADR Term Drug Name Target